专栏名称: 同写意
一个以新药创制为核心,汇集国内一流研发精英的大型交流与价值分享平台。“同筑技术人生路,写意中国新药魂”是同写意的初衷与愿景。秉承汇集“一线、一流”,讲求“实用、实在、时效”的原则。
目录
相关文章推荐
刀法研究所  ·  “年味”淡了?品牌如何用三招在春节破局? ·  昨天  
跟宇宙结婚  ·  节目更新:跟宇宙结婚悄悄话 vol.243 ... ·  昨天  
刀法研究所  ·  OpenAI开放ChatGPT搜索功能;无印 ... ·  昨天  
玩物志  ·  2 万一件!大批「黄牛奶奶」爆炒始祖鸟 ·  3 天前  
51好读  ›  专栏  ›  同写意

【直播】2025年1月生物医药大事讨论

同写意  · 公众号  ·  · 2025-01-31 17:24

正文


各领域专家汇聚在BioSpark Monthly News论坛,交流过去一个月发生的 生物医药领域大事件





本月热点

TOPICS

1 . New Modalities :

  • Sana announces positive clinical results from type 1 diabetes study of islet cell transplantation without immunosuppression;

  • After Novo Nordisk and Biogen, AbbVie became San Diego biotech Neomorph’s third partner in developing molecular glues;


2 . Oncology & Autoimmune Diseases:

  • J NJ’s Amivantamab plus Lazertinib showed statistically significant and clinically meaningful OS improvement vs. Osimertinib in 1L locally advanced or metastatic NSCLC with EGFR mutations;

  • Eli Lilly acquired Scorpion’s mutant-selective PI3Ka inhibitor program for $2.5B;

  • IGM Biosciences halted development of 2 bispecific T cell engagers for autoimmune diseases;


3 . Metabolic & Neurological Diseases

  • Akero Therapeutics reported positive phase 2b results of bivalent FGF21 analog Efruxifermin in MASH patients with biopsy-confirmed compensated cirrhosis;

  • JNJ acquired Intra-Cellular for $14.6B to double down on neurological diseases;

  • Vigil Neuroscience's TREM2-targeted VG-3927 showed early promise in phase 1 Alzheimer's trial, moving on to phase 2;

  • Neumora’s Navacaprant failed the first of three major depression phase 3 trials.



活动详情


主题: Monthly biotech news discussion - January 2025 in review


时间: 2025年2月1日 Sat 8:00 PM(EST)/ 2025年2月2日 周日 早上9:00 AM(北京时间)


地点: zoom meeting(扫描二维码 获得zoom注册链接 或点击文末“阅读原文”


嘉宾

Jimmy Wang (王俊) , Assistant Professor @ New York University

( https://www.linkedin.com/in/jun-jimmy-wang-69a16a58/ )


Ethan Xu (徐亦迅), VP of Bioinformatics @ Aspen Neuroscience

( http://linkedin.com/in/ethan-yixun-xu-2b915a4 )


Haoran Wang(王浩然), CEO @ Neoland Biosciences Co.,Ltd.

( https://www.linkedin.com/in/hao-ran-wang-228648b )


Yanran He (何嫣然 ), Investment Director @ Sinopharm-CICC

( https://www.linkedin.cn/injobs/in/yanranhe )


Leon 'Jun' TANG (唐钧), Founding Partner @ InScienceWeTrust BioAdvisory

( https://www.linkedin.com/in/leontangnyc/ )


Ashley Buckle, Chief Technology Officer & Co-Founder @ Stealth Mode Biotech

( https://www.linkedin.com/in/ashleybuckle/ )


Sean Yao(姚翔) , Co-Founder of Insilico Biosystems

( https://www.linkedin.com/in/xyao2011 )


Hong Yue(岳宏) , Researcher @ Dana-Farber Cancer Insitute / Harvard medical school

( https://www.linkedin.com/in/hong-yue-56392282/ )


Avery Yan (晏庆红) , Founder & CEO @ Riboway Therapeutics

( https://www.linkedin.com/in/avery-yan/ )


Wenjun Wu (Armstrong, 吴文君), Director @ HanKang Venture

( https://www.linkedin.com/in/文君-吴-14787b95/ )


本期活动组织: Ethan Xu

本月热点总结:Armstrong和monthly news嘉宾




活动直播伙伴















请到「今天看啥」查看全文